News & Updates

Show Multimedia Only

$Do calcium, vitamin D supplements prevent fractures, falls?$

Do calcium, vitamin D supplements prevent fractures, falls?

04 Jun 2026 by

The use of calcium, vitamin D, or combined supplementation does not appear helpful in preventing fractures and falls, claims a study.

Do calcium, vitamin D supplements prevent fractures, falls?

04 Jun 2026

Clipping before ECI lowers risk of ectopic embolisms in gastric varices

04 Jun 2026

Adding clip prior to endoscopic cyanoacrylate injection (ECI) helps prevent ectopic embolism in patients with fundal varices with a portal-systemic shunt, without compromising safety or efficacy, as shown in a recent study.

Clipping before ECI lowers risk of ectopic embolisms in gastric varices

04 Jun 2026

One-time gene replacement therapy improves motor function in SMA patients

04 Jun 2026 by

Intrathecal onasemnogene abeparvovec (OAV101 IT), a one-time gene transfer therapy, significantly improves motor function in treatment-naïve patients with spinal muscular atrophy (SMA), as shown by the period 1 results of the phase III STEER study.

One-time gene replacement therapy improves motor function in SMA patients

04 Jun 2026

Lifestyle factors, comorbidities linked to difficult-to-treat rheumatoid arthritis

04 Jun 2026

Difficult-to-treat rheumatoid arthritis is associated with smoking, obesity, fibromyalgia, and depression, according to the results of a meta-analysis.

Lifestyle factors, comorbidities linked to difficult-to-treat rheumatoid arthritis

04 Jun 2026

Multimodal strategies needed to halt progression of MCI and Alzheimer’s disease

04 Jun 2026 by

Early, long-term multimodal interventions are required to halt the progression of mild cognitive impairment (MCI) and Alzheimer’s disease, according to Professor Timothy Kwok of the Division of Geriatrics, Chinese University of Hong Kong (CUHK), who spoke at AIM 2026.

Multimodal strategies needed to halt progression of MCI and Alzheimer’s disease

04 Jun 2026

Donanemab delays Alzheimer's disease progression over 3 years

04 Jun 2026 by

Donanemab administered for a limited duration continues to slow clinical progression in patients with early symptomatic Alzheimer’s disease (AD) over 3 years, according to Professor Chaur-Jong Hu of the Department of Neurology, Taipei Medical University, who spoke at Advances in Medicine (AIM) 2026.

Donanemab delays Alzheimer's disease progression over 3 years

04 Jun 2026

Pre-eclampsia linked to increased risks of hypertension, CKD, CVD in mums

03 Jun 2026

Women with a history of pre-eclampsia may have heightened long-ter risks of hypertension, chronic kidney disease (CKD), and cardiovascular disease (CVD), as reported in a study.

Pre-eclampsia linked to increased risks of hypertension, CKD, CVD in mums

03 Jun 2026

Recent COVID vaccination may reduce transmission

03 Jun 2026 by

Recent COVID-19 vaccination has been linked to a reduced risk of SARS-CoV-2 transmission in a prospective, case-ascertained household transmission study.